$NGM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NGM BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in NGM BIOPHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 17.91 | 33,896 | 607,077 | 16,503,376 | 16.5 M to 16.5 M (+0.21 %) |
| Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 18.00 | 3,751 | 67,518 | 16,469,480 | 16.5 M to 16.5 M (+0.02 %) |
| Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 17.91 | 37,800 | 676,998 | 16,731,176 | 16.7 M to 16.7 M (+0.23 %) |
| Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 17.91 | 33,896 | 607,077 | 16,693,376 | 16.7 M to 16.7 M (+0.20 %) |
| Feb 28 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 18.00 | 3,751 | 67,518 | 16,659,480 | 16.7 M to 16.7 M (+0.02 %) |
| Feb 10 2020 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 15.96 | 44,900 | 716,604 | 298,822 | 253.9 K to 298.8 K (+17.68 %) |
| Feb 10 2020 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 15.96 | 44,900 | 716,604 | 16,465,729 | 16.4 M to 16.5 M (+0.27 %) |
| Feb 10 2020 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 15.96 | 44,900 | 716,604 | 16,655,729 | 16.6 M to 16.7 M (+0.27 %) |
| Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | Trombley Aetna Wun | President & COO | Option Exercise | A | 16.47 | 100,000 | 1,647,000 | 100,000 | |
| Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | A | 16.47 | 175,000 | 2,882,250 | 175,000 | |
| Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | A | 16.47 | 75,000 | 1,235,250 | 75,000 | |
| Feb 06 2020 | NGM | NGM BIOPHARMACEUTI ... | WOODHOUSE DAVID J | CEO and acting CFO | Option Exercise | A | 16.47 | 400,000 | 6,588,000 | 400,000 | |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 1.44 | 18,641 | 26,843 | 154,526 | |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 0.52 | 71,750 | 37,310 | 0 | |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 1.44 | 1,833 | 2,640 | 173,167 | |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 1.44 | 14,201 | 20,449 | 69,444 | |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 1.44 | 16,090 | 23,170 | 83,645 | |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 17.95 | 18,641 | 334,608 | 1,068,443 | 1.1 M to 1.1 M (-1.71 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 1.44 | 18,641 | 26,843 | 1,087,084 | 1.1 M to 1.1 M (+1.74 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 0.52 | 71,750 | 37,310 | 1,068,443 | 996.7 K to 1.1 M (+7.20 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 17.98 | 1,833 | 32,957 | 996,693 | 998.5 K to 996.7 K (-0.18 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 1.44 | 1,833 | 2,640 | 998,526 | 996.7 K to 998.5 K (+0.18 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 17.98 | 14,201 | 255,331 | 996,693 | 1 M to 996.7 K (-1.40 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 1.44 | 14,201 | 20,449 | 1,010,894 | 996.7 K to 1 M (+1.42 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 18.20 | 16,090 | 292,877 | 996,693 | 1 M to 996.7 K (-1.59 %) |
| Jan 09 2020 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 1.44 | 16,090 | 23,170 | 1,012,783 | 996.7 K to 1 M (+1.61 %) |
| Dec 05 2019 | NGM | NGM BIOPHARMACEUTI ... | Guyer Shelly D | Director | Option Exercise | A | 17.24 | 48,355 | 833,640 | 48,355 | |
| Nov 13 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.00 | 15 | 180 | 16,420,829 | 16.4 M to 16.4 M (0.00 %) |
| Nov 13 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.00 | 15 | 180 | 16,610,829 | 16.6 M to 16.6 M (0.00 %) |
| Nov 13 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.00 | 15 | 180 | 253,922 | 253.9 K to 253.9 K (+0.01 %) |
| Nov 13 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.00 | 15 | 180 | 253,922 | 253.9 K to 253.9 K (+0.01 %) |
| Nov 06 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.99 | 8,409 | 100,824 | 16,420,814 | 16.4 M to 16.4 M (+0.05 %) |
| Nov 06 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.99 | 8,409 | 100,824 | 16,610,814 | 16.6 M to 16.6 M (+0.05 %) |
| Nov 06 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.99 | 8,409 | 100,824 | 253,907 | 245.5 K to 253.9 K (+3.43 %) |
| Nov 06 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.99 | 8,409 | 100,824 | 253,907 | 245.5 K to 253.9 K (+3.43 %) |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 1.44 | 10,986 | 15,820 | 99,735 | |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 0.52 | 71,750 | 37,310 | 71,750 | |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 1.44 | 11,403 | 16,420 | 110,721 | |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Option Exercise | M | 1.44 | 28,376 | 40,861 | 122,124 | |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 12.26 | 10,986 | 134,694 | 996,693 | 1 M to 996.7 K (-1.09 %) |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 1.44 | 10,986 | 15,820 | 1,007,679 | 996.7 K to 1 M (+1.10 %) |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 0.52 | 71,750 | 37,310 | 996,693 | 924.9 K to 996.7 K (+7.76 %) |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 13.29 | 11,403 | 151,524 | 924,943 | 936.3 K to 924.9 K (-1.22 %) |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 1.44 | 11,403 | 16,420 | 936,346 | 924.9 K to 936.3 K (+1.23 %) |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Sell | S | 12.99 | 28,376 | 368,565 | 924,943 | 953.3 K to 924.9 K (-2.98 %) |
| Nov 04 2019 | NGM | NGM BIOPHARMACEUTI ... | CHEN JIN-LONG | Chief Scientific Of ... | Buy | M | 1.44 | 28,376 | 40,861 | 953,319 | 924.9 K to 953.3 K (+3.07 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.86 | 2,087 | 24,752 | 16,412,405 | 16.4 M to 16.4 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.00 | 2,300 | 27,600 | 16,410,318 | 16.4 M to 16.4 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.86 | 2,087 | 24,752 | 16,602,405 | 16.6 M to 16.6 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.00 | 2,300 | 27,600 | 16,600,318 | 16.6 M to 16.6 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.86 | 2,087 | 24,752 | 245,498 | 243.4 K to 245.5 K (+0.86 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.00 | 2,300 | 27,600 | 243,411 | 241.1 K to 243.4 K (+0.95 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.86 | 2,087 | 24,752 | 245,498 | 243.4 K to 245.5 K (+0.86 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.00 | 2,300 | 27,600 | 243,411 | 241.1 K to 243.4 K (+0.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,408,018 | 16.4 M to 16.4 M (+0.27 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,364,618 | 16.3 M to 16.4 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,329,897 | 16.3 M to 16.3 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,598,018 | 16.6 M to 16.6 M (+0.26 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,554,618 | 16.5 M to 16.6 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,519,897 | 16.5 M to 16.5 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,408,018 | 16.4 M to 16.4 M (+0.27 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,364,618 | 16.3 M to 16.4 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,329,897 | 16.3 M to 16.3 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,598,018 | 16.6 M to 16.6 M (+0.26 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,554,618 | 16.5 M to 16.6 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,519,897 | 16.5 M to 16.5 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.26 | 34,900 | 358,074 | 16,513,079 | 16.5 M to 16.5 M (+0.21 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.31 | 33,200 | 342,292 | 16,478,179 | 16.4 M to 16.5 M (+0.20 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.36 | 34,900 | 361,564 | 16,444,979 | 16.4 M to 16.4 M (+0.21 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 34,900 | 358,074 | 156,172 | 121.3 K to 156.2 K (+28.78 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.31 | 33,200 | 342,292 | 121,272 | 88.1 K to 121.3 K (+37.70 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.36 | 34,900 | 361,564 | 88,072 | 53.2 K to 88.1 K (+65.64 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 34,900 | 358,074 | 156,172 | 121.3 K to 156.2 K (+28.78 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.31 | 33,200 | 342,292 | 121,272 | 88.1 K to 121.3 K (+37.70 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.36 | 34,900 | 361,564 | 88,072 | 53.2 K to 88.1 K (+65.64 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.26 | 34,900 | 358,074 | 16,323,079 | 16.3 M to 16.3 M (+0.21 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.31 | 33,200 | 342,292 | 16,288,179 | 16.3 M to 16.3 M (+0.20 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.36 | 34,900 | 361,564 | 16,254,979 | 16.2 M to 16.3 M (+0.22 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 16,410,079 | 16.4 M to 16.4 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 16,392,355 | 16.4 M to 16.4 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 16,374,631 | 16.4 M to 16.4 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 16,220,079 | 16.2 M to 16.2 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 16,202,355 | 16.2 M to 16.2 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 16,184,631 | 16.2 M to 16.2 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 53,172 | 35.4 K to 53.2 K (+50.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 35,448 | 17.7 K to 35.4 K (+100.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 17,724 | 0 to 17.7 K |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 53,172 | 35.4 K to 53.2 K (+50.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 35,448 | 17.7 K to 35.4 K (+100.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 17,724 | 0 to 17.7 K |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.99 | 152 | 2,126 | 2,597,816 | 2.6 M to 2.6 M (+0.01 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.98 | 12 | 168 | 2,597,664 | 2.6 M to 2.6 M (0.00 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 14.00 | 224,500 | 3,143,000 | 2,597,652 | 2.4 M to 2.6 M (+9.46 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.99 | 152 | 2,126 | 16,356,907 | 16.4 M to 16.4 M (0.00 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.98 | 12 | 168 | 16,356,755 | 16.4 M to 16.4 M (0.00 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.00 | 224,500 | 3,143,000 | 16,356,743 | 16.1 M to 16.4 M (+1.39 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.99 | 152 | 2,126 | 16,166,907 | 16.2 M to 16.2 M (0.00 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.98 | 12 | 168 | 16,166,755 | 16.2 M to 16.2 M (0.00 %) |
| Aug 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.00 | 224,500 | 3,143,000 | 16,166,743 | 15.9 M to 16.2 M (+1.41 %) |
| Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.96 | 310 | 4,328 | 15,942,243 | 15.9 M to 15.9 M (0.00 %) |
| Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.98 | 5,824 | 81,400 | 15,941,933 | 15.9 M to 15.9 M (+0.04 %) |
| Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.96 | 310 | 4,328 | 16,132,243 | 16.1 M to 16.1 M (0.00 %) |
| Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.98 | 5,824 | 81,400 | 16,131,933 | 16.1 M to 16.1 M (+0.04 %) |
| Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.96 | 310 | 4,328 | 2,373,152 | 2.4 M to 2.4 M (+0.01 %) |
| Aug 07 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.98 | 5,824 | 81,400 | 2,372,842 | 2.4 M to 2.4 M (+0.25 %) |
| Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.97 | 1,782 | 24,898 | 15,936,109 | 15.9 M to 15.9 M (+0.01 %) |
| Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.98 | 2,600 | 36,346 | 15,934,327 | 15.9 M to 15.9 M (+0.02 %) |
| Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.97 | 1,782 | 24,898 | 16,126,109 | 16.1 M to 16.1 M (+0.01 %) |
| Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.98 | 2,600 | 36,346 | 16,124,327 | 16.1 M to 16.1 M (+0.02 %) |
| Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.97 | 1,782 | 24,898 | 2,367,018 | 2.4 M to 2.4 M (+0.08 %) |
| Aug 05 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.98 | 2,600 | 36,346 | 2,365,236 | 2.4 M to 2.4 M (+0.11 %) |
| Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.91 | 8,855 | 123,195 | 15,931,727 | 15.9 M to 15.9 M (+0.06 %) |
| Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.58 | 19,201 | 260,727 | 15,922,872 | 15.9 M to 15.9 M (+0.12 %) |
| Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.91 | 8,855 | 123,195 | 2,362,636 | 2.4 M to 2.4 M (+0.38 %) |
| Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.58 | 19,201 | 260,727 | 2,353,781 | 2.3 M to 2.4 M (+0.82 %) |
| Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.91 | 8,855 | 123,195 | 16,121,727 | 16.1 M to 16.1 M (+0.05 %) |
| Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.58 | 19,201 | 260,727 | 16,112,872 | 16.1 M to 16.1 M (+0.12 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.59 | 30,059 | 408,634 | 2,334,580 | 2.3 M to 2.3 M (+1.30 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.37 | 30,753 | 411,294 | 2,304,521 | 2.3 M to 2.3 M (+1.35 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.51 | 29,054 | 392,502 | 2,273,768 | 2.2 M to 2.3 M (+1.29 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.59 | 30,059 | 408,634 | 16,093,671 | 16.1 M to 16.1 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.37 | 30,753 | 411,294 | 16,063,612 | 16 M to 16.1 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.51 | 29,054 | 392,502 | 16,032,859 | 16 M to 16 M (+0.18 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.59 | 30,059 | 408,634 | 16,093,671 | 16.1 M to 16.1 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.37 | 30,753 | 411,294 | 16,063,612 | 16 M to 16.1 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.59 | 30,059 | 408,634 | 15,903,671 | 15.9 M to 15.9 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.51 | 29,054 | 392,502 | 16,032,859 | 16 M to 16 M (+0.18 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.37 | 30,753 | 411,294 | 15,873,612 | 15.8 M to 15.9 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.51 | 29,054 | 392,502 | 15,842,859 | 15.8 M to 15.8 M (+0.18 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.59 | 30,059 | 408,634 | 15,903,671 | 15.9 M to 15.9 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.37 | 30,753 | 411,294 | 15,873,612 | 15.8 M to 15.9 M (+0.19 %) |
| Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.51 | 29,054 | 392,502 | 15,842,859 | 15.8 M to 15.8 M (+0.18 %) |
| Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.35 | 30,760 | 410,535 | 16,003,805 | 16 M to 16 M (+0.19 %) |
| Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.54 | 30,760 | 416,337 | 15,973,045 | 15.9 M to 16 M (+0.19 %) |
| Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.99 | 6,222 | 87,043 | 15,942,285 | 15.9 M to 15.9 M (+0.04 %) |
| Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.35 | 30,760 | 410,535 | 15,813,805 | 15.8 M to 15.8 M (+0.19 %) |
| Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.54 | 30,760 | 416,337 | 15,783,045 | 15.8 M to 15.8 M (+0.20 %) |
| Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.99 | 6,222 | 87,043 | 15,752,285 | 15.7 M to 15.8 M (+0.04 %) |